COc1cccc(-c2ccc3c(c2)O[C@H](CN(C)C(=O)c2ccccc2F)[C@H](C)CN([C@H](C)CO)S3(=O)=O)c1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?